- Home
- ENSC vs BOF Comparison
ENSC vs BOF Comparison
Compare ENSC & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENSC
- BOF
- Stock Information
- Founded
- ENSC 2003
- BOF 2017
- Country
- ENSC United States
- BOF United States
- Employees
- ENSC 8
- BOF N/A
- Industry
- ENSC Biotechnology: Pharmaceutical Preparations
- BOF Packaged Foods
- Sector
- ENSC Health Care
- BOF Consumer Staples
- Exchange
- ENSC Nasdaq
- BOF Nasdaq
- Market Cap
- ENSC 9.5M
- BOF 12.5M
- IPO Year
- ENSC N/A
- BOF 2023
- Fundamental
- Price
- ENSC $0.69
- BOF $1.91
- Analyst Decision
- ENSC
- BOF
- Analyst Count
- ENSC 0
- BOF 0
- Target Price
- ENSC N/A
- BOF N/A
- AVG Volume (30 Days)
- ENSC 83.4M
- BOF 694.1K
- Earning Date
- ENSC 11-12-2024
- BOF 11-19-2024
- Dividend Yield
- ENSC N/A
- BOF N/A
- EPS Growth
- ENSC N/A
- BOF N/A
- EPS
- ENSC N/A
- BOF N/A
- Revenue
- ENSC $4,421,404.00
- BOF $5,215,452.00
- Revenue This Year
- ENSC N/A
- BOF N/A
- Revenue Next Year
- ENSC N/A
- BOF N/A
- P/E Ratio
- ENSC N/A
- BOF N/A
- Revenue Growth
- ENSC 40.41
- BOF 703.78
- 52 Week Low
- ENSC $0.14
- BOF $0.61
- 52 Week High
- ENSC $2.06
- BOF $4.11
- Technical
- Relative Strength Index (RSI)
- ENSC 61.12
- BOF 60.04
- Support Level
- ENSC $0.62
- BOF $1.72
- Resistance Level
- ENSC $0.81
- BOF $2.20
- Average True Range (ATR)
- ENSC 0.15
- BOF 0.14
- MACD
- ENSC 0.01
- BOF 0.04
- Stochastic Oscillator
- ENSC 53.71
- BOF 66.18
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.